EQUITY ALERT: The Rosen Law Firm Announces Investigation of Lyris, Inc. Concerning its Proposed Sale to Aurea
May 08, 2015
OTC Disclosure News Service
The Rosen Law Firm, a global investor rights law firm, announces that it
is investigating the Board of Directors of Lyris, Inc. (OTCMKTS:LYRI)
for possible breaches of fiduciary duty and other violations of law by
failing to adequately shop Lyris to maximize shareholder value before
agreeing to be acquired by Aurea.
If you would like to join the action, go to the firm’s website at http://rosenlegal.com/cases-607.html
or contact Phillip Kim or Kevin Chan toll-free at 866-767-3653 or via
e-mail at email@example.com
or firstname.lastname@example.org. There
is no cost or obligation to you.
Under the terms of the proposed transaction, shareholders will receive
$0.89 in cash for each share of Lyris common stock they own and $2.50 in
cash for each share of Lyris preferred stock they own. The investigation
relates to whether the proposal is fair to the public shareholders of
Lyris and whether Lyris’s Board breached its fiduciary duties in
connection with the proposed sale.
If you currently own shares of Lyris and wish to obtain additional
information, please visit the firm’s website at http://rosenlegal.com/cases-607.html.
You may also contact Phillip Kim or Kevin Chan of The Rosen Law Firm
toll free at 866-767-3653 or via e-mail at email@example.com
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and shareholder
Attorney Advertising. Prior results do not guarantee a similar outcome.
Copyright © 2015 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.